NCT01436500 - Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

June 30, 2015

Study Completion Date

July 31, 2015

Conditions

Hepatorenal Syndrome

Interventions

DRUG

Ifetroban Injection

Ifetroban sodium injectable, diluted in sterile water with 5% dextrose

DRUG

Placebo

Sterile water with 5% Dextrose

Trial Locations (12)

NYU Langone Medical Center, New York

Virginia Commonwealth University, Richmond

Emory University Hospital, Atlanta

The Ohio State University, Columbus

Indiana University (Division of Gastroenterology/Hepatology), Indianapolis

University of Michigan Hospital, Ann Arbor

Baylor All Saints Medical Center, Fort Worth

University of Utah Health Sciences Center, Salt Lake City

Mayo Clinic - Arizona, Phoenix

UCSD, Hillcrest Medical Center Hospital, La Jolla

UCSF (University of California-San Francisco), San Francisco

MIDAS Multispeciality Hospital PVT LTD, Nagpur